Evidence map›Paper›PMID 29337896›Full record

ArticleInternational journal of molecular sciences2018

Caffeic Acid and Metformin Inhibit Invasive Phenotype Induced by TGF-β1 in C-4I and HTB-35/SiHa Human Cervical Squamous Carcinoma Cells by Acting on Different Molecular Targets.

Malgorzata Tyszka-Czochara, Malgorzata Lasota, Marcin Majka

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Caffeic Acid and Diseases-Mechanisms of Action.International journal of molecular sciences · 2022
    Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Vimentin as a target for the treatment of COVID-19.BMJ open respiratory research · 2020
    Article
  16. Article
  17. Mechanisms of metformin inhibiting cancer invasion and migration.American journal of translational research · 2020
    Review
  18. Article
  19. RSC advances · 2019
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Malgorzata Tyszka-CzocharaDepartment of Food Chemistry and Nutrition, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9, 30-688 Krakow, Poland. mtyszka@poczta.fm.ORCID 0000-0001-7945-1039
Malgorzata LasotaChair of Medical Biochemistry, Faculty of Medicine, Jagiellonian University-Medical College, Kopernika 7, 31-034 Krakow, Poland. malgorzata.lasota@uj.edu.pl.
Marcin MajkaDepartment of Transplantation, Faculty of Medicine, Jagiellonian University Medical College, Wielicka 258, 30-688 Krakow, Poland. mmajka@cm-uj.krakow.pl.ORCID 0000-0002-0429-681X
Jagiellonian University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the progression of epithelial cancer, the cells may lose epithelial markers and gain mesenchymal phenotype via Epithelial-Mesenchymal Transition (EMT). Such transformation of epithelial cancer cells to mesenchymal-like characteristic benefits plasticity and supports their ability to migrate. The aim of this study was to evaluate the influence of natural compound Caffeic Acid (CA) alone and in combination with antidiabetic drug Metformin (Met) on metastatic progression of two human cervical squamous cell cancer lines, C-4I and HTB-35/SiHa cells. EMT program was triggered by exposition of both epithelial cell lines to TGF-β1. Gene expression patterns related to epithelial/mesenchymal phenotype were evaluated by Real-Time PCR analysis and the protein amount was detected by western blot. The treatment of human squamous cancer cells with CA and with Met, suppressed the motility of cells and the effect depended on a particular cell line. Both compounds regulated the EMT process in C4-I and HTB-35 cells by interfering with different molecular targets. In TGF-β1-stimulated C4-I cells, CA suppressed the expression of mesenchymal transcription factor SNAI1 which resulted in enhanced expression of epithelial markers E-cadherin, Occludin and Claudin. Additionally, CA blocked

Indexed as

Molecular Targeted TherapyBiomarkers, TumorCaffeic AcidsCarbonic Anhydrase IXCarcinoma, Squamous CellCell AdhesionCell HypoxiaCell Line, TumorCell MovementDown-RegulationEpithelial-Mesenchymal TransitionFemaleHumansMatrix Metalloproteinase 9MetforminModels, BiologicalBiomarkers, Tumorcaffeic acidCaffeic AcidsCarbonic Anhydrase IXMatrix Metalloproteinase 9MetforminTissue Inhibitor of Metalloproteinase-1Transcription FactorsTransforming Growth Factor beta1caffeic acidcarbonic anhydrase IXcervical cancerepithelial markersepithelial-mesenchymal transitionhypoxiamesenchymal markersmetastasismetformin

Identifiers

PMID29337896
PMCPMC5796212
OpenAlexW2788208950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.